Reading Time: 6 minutes Source link | Twitter Profile | Website Market Capitalization: 6,300 Cr Current Price: 1,933 (26 Oct 2020) Stock P/E: 30 Debt to equity: 0.09 Sales Growth (3Yrs): 11.3% Profit Growth (3Yrs): 43% ROCE: 49% ROE: 26.9% Promoter holding: 58.3% Cash Cycle: 69 days Asset Turnover: 2.23 Net Profit Margin: 9.9% Overview of the Company Vaibhav Global Limited (VGL) was established in 1980 by Mr. […]
Alembic Pharma – Market Leader in Anti-Infective Drugs
Reading Time: 6 minutes Source link | Twitter Profile | Website Market Capitalization: 19,176.56 Cr Current Price: 977 (23 Oct. 2020) Stock P/E: 1969 Debt to equity: 0.54 Sales Growth (3Yrs): 11.4% Profit Growth (3Yrs): 31.1% ROCE: 26% ROE: 32 % Promoter holding: 73% Cash Cycle: 94 days Asset Turnover: 0.86 Net Profit Margin: 17.4% ABOUT THE COMPANY Let’s dig deeper into Alembic Pharma Company Analysis. APLLTD is […]
Xelpmoc Design and Tech Ltd – stockdigest
Reading Time: 7 minutes ‘Info Edge’ in Startup Phase Market Capitalization: 350 Cr Current Price: 248 (16 Oct 2020) Stock P/E: 376 Debt to equity: 0 Promoter holding: 58.2% Net Profit Margin: NA Overview of the Company Founded in 2015, Xelpmoc Design and Tech Limited (Xelp) is an end-to-end professional & technology service provider with a keen focus on product development, data […]
Apollo Tricoat Tubes – 9 Points Significant Analysis and Important Points
Reading Time: 6 minutes Source link | Twitter Profile | Website Overview of Apollo Tricoat Market Capitalization: 1,809 Cr Current Price: 600 (1 Oct 2020) Stock P/E: 38 Debt to equity: 0.56 Sales Growth (3Yrs): 121% Profit Growth (3Yrs): 208% ROCE: 26.1% ROE: 26.1% Promoter holding: 62.6% Cash Conversion Cycle: 5 days Asset Turnover: 1.72 Net Profit Margin: 6.3% Apollo Tricoat Tubes Ltd (ATTL), formerly known […]
Astec LifeSciences Company Analysis
Reading Time: 5 minutes Source link | Twitter Profile Brief Overview of the Company Let’s dig deeper into Astec Lifesciences Company Analysis. Market Capitalization: 2,107 Cr Current Price: 1,076 (27 Sep 2020) Stock P/E: 32.6 Debt to equity: 0.4 Sales Growth (3Yrs): 20.5% Profit Growth (3Yrs): 21.8% ROCE: 20.4% ROE: 21.2% Promoter holding: 72.3% Cash Cycle: 61 days Asset Turnover: 1.21 Net Profit Margin: 11.6% Astec LifeSciences […]
Birlasoft Limited Stock Analysis
Reading Time: 5 minutes Source link Let’s delve deeper into the Birlasoft Limited Stock Analysis. Market Capitalization: 5,409 Cr Current Price: 195 (19 Sep 2020) Stock P/E: 22.7 Debt to equity: 0 Sales Growth (3Yrs): -0.3% Profit Growth (3Yrs): 0.1% ROCE: 19.3% ROE: 12.6% Promoter holding: 40.8% Cash Cycle: 53 days Asset Turnover: 1.32 Net Profit Margin: 7.0% ABOUT THE COMPANY Birlasoft Ltd (Birlasoft), a CK […]
Suven Pharma Company Analysis
Reading Time: 4 minutes Let’s dig deeper into Suven Pharma Company Analysis. Market Capitalization: 9,224 Cr Current Price: 724 (14 Sep 2020) Stock P/E: 29.1 Debt to equity: 0.24 Sales Growth (2Yrs): 15.5% Profit Growth (2Yrs): 41.6% ROCE: 46.2% ROE: 39.7% Promoter holding: 60% Cash Cycle: 81 days Asset Turnover: 1.12 Net Profit Margin: 36.2% ABOUT THE COMPANY Suven Pharmaceuticals Ltd (SPL) demerged away from Suven […]
Mastek Ltd – stockdigest
Reading Time: 6 minutes Market Capitalization: 1,617 Cr Current Price: 700 (13 Aug 2020) Stock P/E: 12 Debt to equity: 0.42 Sales Growth (3Yrs): 25.2% Profit Growth (3Yrs): 95.6% ROCE: 20.7% ROE: 19.2% Promoter holding: 38.2% Cash Cycle: 56 days Asset Turnover: 0.71 Net Profit Margin: 11.6% ABOUT THE COMPANY Mastek Limited (Mastek) is an information technology (IT) solutions provider. The Company and its subsidiaries […]